This survey, conducted in tandem with a written version administered statewide, ~s examined the attitudes and practices of pharmacists. It was hypothesized that pharmacists who provided and supported providing public health and HIV-related services would be more likely to support nonprescription syringe sales to IDUs. The survey attempted to assess public health attitudes and practices of pharmacists in neighborhoods of each borough of New York City and to identify concerns among pharmacists about the nonprescription sale of syringes to IDUs.
METHODS
A telephone survey of pharmacists in New York City neighborhoods with high IDU-related AIDS prevalence was conducted to assess pharmacists' current attitudes and practices toward pharmacy sale of syringes to IDUs.
The sample was drawn from pharmacists employed at pharmacies in the three "neighborhoods" (as delineated by postal code by the New York City Hospital 
RESULTS
Of the sample contacted, 20 had disconnected or incorrect telephones, the pharmacist was unavailable in 13, and 23 refused to participate; 126 completed the survey by telephone, and 4 completed the survey by fax. Of those who refused to participate, 10 were "too busy," 4 were not interested, and 4 told the interviewer to contact the "home office" of the chain. Only 1 reported distaste for the law as a reason not to participate; 2 said the law is a "great idea," but were too busy to participate. Refusal rates did not differ by borough.
Of those surveyed, 37.7% were owners, 40.8% were managers or supervisors, and 20.0% were staff pharmacists; 74.4% were male; 39.8% were white, and 30.9%
were Asian or Pacific Islander. The median year in which pharmacists had received their license was 1985, reflecting a median of 15 years in practice.
Of the pharmacies, 71.5% were independently owned; 28.5% were chains or Less than half (47.7%) of pharmacists were aware of the new law. Nearly all (94.6%) were personally "somewhat" or "very willing" to provide nonprescription sale of syringes to a "known diabetic" (see Fig. 2 ). However, only 40.5%
were willing to sell to an IDU; 11.5% were very willing. In contrast, 72.4% were willing to sell to an IDU "with a referral card from an agency or clinic." These data were grouped as "somewhat/very willing" and "not willing" for further analysis; "undecided" responses (n < 6) were excluded.
Of the pharmacists, 37% personally supported having their pharmacy provide "nonprescription sale of needles and syringes to injection drug users"; 6.9% were undecided; 56.2% were not supportive. Willingness to sell syringes to IDUs and support for syringe sales to IDUs were consistent internally (Chronbach Diabetic IDU iDU with Support referral sales to IDU
Pharmacists' willingness to sell needles/syringes without a prescription to diabetics and injection drug users (IDUs) and personal support for nonprescription sales to IDUs (prior to law change telephone survey, New York City, July-August 2000). alpha = .72). A total of 49.6% of pharmacists was either willing to sell syringes to IDUs or personally supported providing that service. About half (53.6%) of pharmacists that did not support syringe sales to IDUs were willing to sell to IDUs with a referral card. There were no differences associated with awareness of the new law.
Pharmacists undecided about support for syringe sales to IDUs were somewhat less likely than decided pharmacists to be concerned about legal liability for syringe sales to IDUs (P = .08), to believe that selling syringes to IDUs would increase discarded syringes in the neighborhood (P = .008) or drug use (P = .08), and to believe that the community would respond negatively to the policy (P = .08). Undecided pharmacists also appeared more willing than decided pharmacists to sell syringes to IDUs with a referral card (P = .186). For these reasons and due to limited sample size, undecided cases (N = 9) were grouped with pharmacists that supported syringe sales to IDUs in further analysis.
Most characteristics of pharmacists (see Table I ) and pharmacies (see Table   II ) were not associated with support for syringe sales to IDUs. Managers and supervisors tended to be more likely than staff pharmacists to support syringe sales to IDUs (P = .076). Support for syringe sales to IDUs differed somewhat by borough (P = .078) due to the difference between the proportion of pharmacists in support of syringe sales to IDUs in Queens (27%, 95% C114-44%) and Brooklyn (62%, 95% CI 46--81%).
Factors most often rated very important in influencing whether a pharmacist would sell syringes without a prescription were the risk of discarded syringes in or around the pharmacy (78.9%), safety of self and staff (75.6%), and concern for HIV prevention among IDUs (74.4%). Factors least often rated very important were potential income (7.9%) and presence of other customers (16.2%). Factors were grouped as concerns about safety, the context of sale, and customer-related issues and compared to support for syringe sales to IDUs (see Table III ). Safety factors, including risk of theft and legal liability, were not predictive of support, although concern about the risk of discarded needles (P = .19) and drug use on premises (P = .20) were somewhat associated with nonsupport. Most context-ofsale factors, including customer sobriety, customer knowledge about syringes, insulin and diabetes, customer familiarity and potential income from the nonprescription sale of syringes, were not associated with support. Appearance of customers (P = .07) and presence of other customers (P = .15) were somewhat associated with nonsupport. Willingness to provide nonprescription sales of packs of 10 syringes (P < .001) and, to a lesser extent, sale of single syringes (P = .017) were associated significantly with support for syringe sales to IDUs.
Of customer-related factors, concern for HIV prevention among IDUs was not associated with support for syringe sales to IDUs. Willingness to sell to a diabetic (P = .019), IDU (P < .001), and IDU with a referral card (P < .001) were associated strongly with support for syringe sales to IDUs. Table IV ):
Pharmacists were asked if they supported having their pharmacy offer a *"Somewhat/very willing" to sell syringes without a prescription.
variety of public health services. The majority supported providing free sharps disposal containers (66.2%), pamphlets and counseling on safer sex practices (92.3%), pamphlets (85.4%) and counseling (80.0%) on safer intravenous drug injection, and referrals to drug treatment (93.1%). A significant minority of all pharmacists (24.6%) supported providing sharps containers in the store for customers to discard used syringes. Support for providing syringe exchange in the pharmacy was low among all pharmacists (12.3%), but significantly associated with support for syringe sales to IDUs (P = .013) (see Table V ).
Among managing or supervising pharmacists (i.e., those with decision-making authority), the availability of syringes in packs of 10 (P < .1) and personal sharps containers for retail sale (P = .06) tended to be associated with support for syringe sales to IDUs (see Table VI ). Results were not dependent on pharmacy characteristics. It is reasonable to expect that pharmacists' attitudes and practices regarding public health and HIV would influence their willingness to sell syringes to IDUs.
In fact, managing or supervising pharmacists who stocked female condoms, packs of 10 syringes, and sharps disposal containers were somewhat more likely to support syringe sales to IDUs than those who did not stock these supplies; because staff pharmacists do not have control over stocking supplies, the observation of no such association found with staff pharmacists was not unexpected.
Although concerns about safety and HIV transmission among IDUs were cited most frequently as influencing pharmacists' decisions to sell syringes without a prescription, only customer appearance was associated with nonsupport of syringe sale to IDUs, consistent with reports of pharmacists elsewhere. 2~ Finally, pharmacists in support of syringe sales to IDUs tended to be less likely to believe drug use would increase and were significantly more likely to support syringe exchange in their pharmacy.
Disposal of syringes was a concern among all pharmacists, regardless of level Health authorities should build on these concerns through tailored continuing education programs, informational campaigns with data on pharmacy sale of syringes and HIV prevention, and initiatives to address the likely perception of increased numbers of improperly disposed syringes. Pharmacist associations should also continue to express support for syringe sales to IDUs.
